Diagnosis |
|
|
|
|
|
|
|
Delpierre, 2006
|
France |
Prospective multicenter cohort |
Patients from 6 hospitals from 1996–2005 (N = 5702) |
Non-probability sample of all patients who sought care from 6 hospitals |
Employment status: stable employment, on employment benefits, unemployed or other |
Late testing: presenting with symptoms of AIDS or CD4 < 200 mm3 during the year of diagnosis |
Among MSM, unemployment associated with late testing (OR = 2.23, 95% CI 1.14–4.36); among women and heterosexuals employment status not associated with late testing |
Massari, 2011
|
France |
Prospective cohort |
General population living in the Paris metropolitan area, SIRS Cohort (N = 3023) |
Multistage, random sample |
Employment status: employed, unemployed and inactive, which includes retired or student |
HIV testing: Never having been tested for HIV |
Among women, unemployment was associated with no history of HIV testing (OR 1.85, 95% CI 1.24–2.77). Among men, a significant association was not observed |
D’Arminio, 2011
|
Italy |
Observational Cohort Study |
Antiretroviral-naïve patients with a recent HIV diagnosis and CDC + T-cell count (N = 2276) |
All patients enrolled in the Icona Foundation Study who met eligibility criteria from 1997 to 2009 |
Employment status: becoming unemployed, as opposed to retiring |
Late diagnosis: patients presenting with symptoms of AIDS or CD4 T-cell count less than or equal to 350/mm3
|
Unemployment (in comparison to retirement) was associated with late diagnosis (OR = 0.36, 95% CI 0.21–0.61) |
Sheehan, 2017
|
Florida, USA |
Surveillance study |
Florida Department of Health Enhanced HIV/AIDS Reporting System and American Community Survey (eHARS)(N = 5522) |
Reported surveillance cases between 2007 and 2011 |
Neighborhood employment level: the percent of the population who is 16 of older and are unemployed |
Late diagnosis: receiving an AIDS diagnosis within 3 months of receiving their HIV diagnosis |
Among Latino men, neighborhood unemployment strata were associated with late testing. By 2nd, 3rd, and 4th strata of unemployment, ORs (95% CIs): 1.37 (1.06–1.78), 1.29 (1.01–1.66), 1.33 (1.03–1.72) |
Linkage to HIV Care |
|
|
|
|
|
|
|
Girardi, 2004
|
Italy |
Multi-center cohort |
Individuals living with HIV over the age of 18 (n = 4453) |
Antiretroviral-naïve patients enrolled from 59 clinical centers from 1997 to 2000 |
Employment status, coded as stable employment, unemployed, or other |
Delayed presentation: greater than 6 months from positive test result to presenting for HIV medical care |
Unemployment associated with delayed presentation to care (OR = 2.75, 95% CI 1.66–4.53) |
Aaron, 2015
|
Philadelphia, USA |
Retrospective cohort |
Individuals with an HIV positive diagnosis who attended a large urban healthcare center (n = 87) |
Medical records were used to ascertain HIV positive diagnoses in inpatient and outpatient settings from 2007 to 2011 |
Employment status: dichotomous variable, where either employed or unemployed |
Linkage to care: one visit to an HIV medical provider within 6 months of receiving a positive test result |
Unemployment was associated with failure to link to care (OR = 6.50, 95% CI 1.13–37.32) |
Nijhawan, 2017
|
Texas, USA |
Retrospective chart review |
Individuals who were scheduled for a new patient visit after January 1st, 2014 from two clinics (n = 200; 100 per clinic) |
Consecutive sample of patient records from 2014–2016 |
Employment status, coded as employed, unemployed, or disabled |
Linkage to care: missing vs. attending the first scheduled medical visit |
Unemployment was associated with missing the first scheduled appointment. (OR = 2.33, 95% CI 1.04–5.24) |
Retention in HIV care |
|
|
|
|
|
|
|
Joy, 2008
|
British Columbia, Canada |
Prospective cohort |
Treatment-naïve patients accessing HAART between September 1, 1997 and November 30, 2004 (n = 2168) |
Enrollment in provincial drug treatment program (the only method by which patients can access HAART in British Columbia) |
Neighborhood measurement of percentage of unemployed individuals |
Delayed access to treatment: not accessing treatment until patient’s CD4 count was low (< 50 cells/mm) |
Unemployment was associated with delayed access to treatment (OR = 1.41, 95% CI 1.14–1.74) |
Shacham, 2013
|
St Louis, USA |
Cross-sectional study |
All patients who attended the Washington University HIV clinic in 2008 (n = 762) |
All patients who attended the Washington University HIV clinic in 2008 were required to complete a behavioral survey as a part of their medical visit. Data was gathered from these surveys |
Employment level, measured as a neighborhood-level variable |
Receipt of ART prescription:, use of at least three drugs from two different antiretroviral drug classes or the use of at least three nucleoside reverse transcriptase inhibitors |
Neighbourhoods with higher rates of unemployment had individuals who were less likely to have a current ART prescription (OR = 1.47, 95% CI 1.05–2.04) |
HIV medication adherence |
|
|
|
|
|
|
|
Torres-Madriz, 2011
|
Boston, USA |
Randomized, crossover trial |
Patients on ART with a detectable viral load in the greater Boston area (n = 156) |
Convenience sample of patients from five patient care settings |
Work accommodations dichotomized as any or none |
ART adherence: percentage of doses taken correctly during the 30 days prior to each study visit |
Patients with accommodations had a 12% higher mean adherence than those without accommodations (Parameter estimate 0.12, 95% CI 0.03–0.20) |
Nachega, 2015
|
N/A – previously conducted trials were used |
Meta-analysis |
28 articles meeting all criteria were included. This yielded information on 8743 individuals from 14 different countries |
Records were identified from Medline, Embase, and Cochrane Central Register of Controlled Trials |
Employment was globally assessed across all the included studies |
Adherence was globally assessed across all the included studies |
In low and high-income countries, being employed was favorably linked to adherence. Low: (OR = 1.85, 95% CI 1.58–2.18);Middle: (OR = 0.94, 95% CI 0.62–1.42); High: (OR = 1.33, 95% CI 1.02–1.74) |
Viral load |
|
|
|
|
|
|
|
Dray-Spira, 2005
|
France |
Prospective cohort study |
Patients from 66 hospitals across France, enrolled between 1996 and 2002 (n = 319) |
Convenience sample of patients recruited through hospitals who were recently diagnosed and ARV-naïve |
Employment loss: change from employment to inactivity between two semi-annual visits |
High viral load: greater than 10,000 copies/mm3
|
Both persistent and incident high viral loads were associated with employment loss. Respectively, (OR = 2.4, 95% CI 1.1–5.0); (OR = 3.7, 95% CI 1.0–13.9) |